Johnson & Johnson

JNJ · NYSE
Analyze with AI
9/28/2025
6/29/2025
3/30/2025
12/31/2024
Operating Activities
Net Income$5,152$5,537$10,999$3,431
Dep. & Amort.$1,777$1,943$1,772$1,896
Deferred Tax$2,218$825$2,172-$16
Stock-Based Comp.$347$410$288$238
Change in WC$15,945-$4,921-$11,024$798
Other Non-Cash-$16,270$84-$33$636
Operating Cash Flow$9,169$3,878$4,174$6,983
Investing Activities
PP&E Inv.-$1,157-$1,043-$795-$1,612
Net Acquisitions-$1-$14,458$0-$1
Inv. Purchases$2,438-$2,864-$251-$262
Inv. Sales/Matur.$489$735$218$290
Other Inv. Act.-$2,311-$634$531$265
Investing Cash Flow-$542-$18,264-$297-$1,320
Financing Activities
Debt Repay.-$7,109-$2,376$15,051$1,535
Stock Issued-$4,029$107$0$0
Stock Repurch.$0$0-$2,127-$282
Dividends Paid-$3,132-$3,129-$2,989-$2,984
Other Fin. Act.$5,343-$267$487$391
Financing Cash Flow-$8,927-$5,665$10,422-$1,340
Forex Effect-$46$154$70-$198
Net Chg. in Cash-$346-$19,897$14,369$4,125
Supplemental Information
Beg. Cash$18,577$38,474$24,105$19,980
End Cash$18,231$18,577$38,474$24,105
Free Cash Flow$8,381$2,480$3,365$4,838